Intensive blood glucose lowering treatment proved fatal for diabetes patients

Intensive blood glucose lowering treatment proved fatal for diabetes patients in a US study, and for Safety, National Heart, Lung, and Blood Institute (NHLBI) has changed intensive blood sugar treatment strategy in clinical trial of diabetes and cardiovascular disease.

In this trial of adults with type 2 diabetes at especially high risk for heart attack and stroke, the medical strategy to intensively lower blood glucose (sugar) below current recommendations increased the risk of death compared with a less-intensive standard treatment strategy. Study participants receiving intensive blood glucose lowering treatment will now receive the less-intensive standard treatment.

The ACCORD (Action to Control Cardiovascular Risk in Diabetes) study enrolled 10,251 participants. Of these, 257 in the intensive treatment group have died, compared with 203 within the standard treatment group. This is a difference of 54 deaths, or 3 per 1,000 participants each year, over an average of almost four years of treatment. The death rates in both groups were lower than seen in similar populations in other studies.

"A thorough review of the data shows that the medical treatment strategy of intensively reducing blood sugar below current clinical guidelines causes harm in these especially high-risk patients with type 2 diabetes," said Elizabeth G. Nabel, M.D., director, NHLBI. "Though we have stopped this part of the trial, we will continue to care for these participants, who now will receive the less-intensive standard treatment. In addition, we will continue to monitor the health of all participants, seek the underlying causes for this finding, and carry on with other important research within ACCORD."

In stopping this part of the trial, Nabel accepted the recommendation of the 10-member Data and Safety Monitoring Board (DSMB) – an independent advisory group of experts in diabetes, cardiovascular disease, epidemiology, patient care, biostatistics, medical ethics, and clinical trial design that has been monitoring ACCORD since it began.

(Published at Health News Track on February 7, 2008 - 335 days ago)

Diabetes article/news source:

National Heart, Lung, and Blood Institute - read other health news articles from National Heart, Lung, and Blood Institute and health news articles from USA.

Diabetes - related articles/news stories:

- Diabetes slows mental functioning in adults
- Blood sugar level linked to cognitive aging
- Low glycemic diet better for type 2 diabetes patients
- Diabetes drugs double fractures risk in women
- Diabetes drug rosiglitazone linked to higher heart failure risk
- Children of centenarians live longer with no heart disease, stroke, diabetes
- Genetic screening for diabetes not helpful
- Lilly donated Insulin to International Diabetes Federation's Life for a Child Program
- Nicole Johnson takes action for type 1 diabetes research
- Mislabeled ReliOn Insulin Syringes recalled in US


»» FDA updates guidance to seafood processors after recent ciguatera poisoning
«« Teenage fathers have babies with birth problems

The information provided on Health Newstrack is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.
We comply with the HONcode principles for trustworthy health information, verify here.
www.healthnewstrack.com - About us, Editorial team, Advertising, Jobs, Links, Privacy policy, Disclaimer, Feedback,
Site map, List health news, Health news organizations, Health news world, Accessibility, Glossary, Testimonials, Blog
Mobile/PDA Submit press release
© 2007-2008 HealthNewstrack.com
Track Health News Daily
4.62